| |
|
|
|
Aldeyra Therapeutics Inc.  
|
|
7.76 0.07 (0.01%) |
04-18 16:00 |
|
Open: |
7.69 |
Pre close: |
7.69 |
Target:
|
12.27
|
|
High: |
7.82 |
Low: |
7.56 |
Resistance:
|
10.51
12.79
|
|
Volume: |
258,406 |
Market Cap: |
213M |
Support:
|
6.81
5.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.91
 |
MACD |
MACD(12,26):
|
-0.14 |
|
MA(20): |
8.46 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
8.55 |
Stochastic Oscillator |
%K(14,3):
|
8.39  |
|
MA(250): |
8.79 |
%D(3): |
7.00 |
|
Average Volume(K) |
3-Month: |
69250
|
52-Week |
High:
|
16.70 |
|
10-Days: |
30395 |
Low: |
6.75 |
|
RSI |
RSI(14):
|
41.97 |
Change(%): |
10.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.800 |
Return on Equity (ttm) |
-61.6 |
Shares Out. (M) |
27.40 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-55.8 |
Shares Float (M) |
26.68 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.40 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
92.40 |
|
Forward EPS |
-2.372 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.630 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.95 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-29.86 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-41.81 |
P/CF |
-7.12 |
|
|
|
|
|
|
